Article
Targeted therapies of solid cancers
22 Mar 2013
Abstract excerpt
PURPOSE OF REVIEW: The landscape of medical oncology is filled with approvals of new anticancer agents, the majority of which are targeted agents. This shift in therapies raises multiple challenges including the appearance of new toxicities, the need for biomarkers, the emergence of genomics and the evolution of cancer molecular imaging. RECENT FINDINGS: Biopsy of metastatic lesions is slowly becoming a standard...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
